CarbonSilicon AI
CarbonSilicon AI Technology Development Co., Ltd is a technology company focused on new drug research and development, providing AI infrastructure and services for drug discovery. Their flagship product is DrugFlow, an AI-powered SaaS platform for preclinical drug discovery that integrates AI and physical computing to enhance accuracy and usability across modules like target discovery, virtual screening, lead optimization, and safety prediction. They also offer an open AI platform OpenDrug for model building and deployment, and a Contract AI Research Organization (CARO) service model for collaborative AI-driven drug discovery projects. The company aims to transform drug R&D by combining AI, automation, and expert knowledge to accelerate and improve success rates in innovative drug development, positioning itself as a leading intelligent drug R&D platform in China.
CarbonSilicon AI
CarbonSilicon AI Technology Development Co., Ltd is a technology company focused on new drug research and development, providing AI infrastructure and services for drug discovery. Their flagship product is DrugFlow, an AI-powered SaaS platform for preclinical drug discovery that integrates AI and physical computing to enhance accuracy and usability across modules like target discovery, virtual screening, lead optimization, and safety prediction. They also offer an open AI platform OpenDrug for model building and deployment, and a Contract AI Research Organization (CARO) service model for collaborative AI-driven drug discovery projects. The company aims to transform drug R&D by combining AI, automation, and expert knowledge to accelerate and improve success rates in innovative drug development, positioning itself as a leading intelligent drug R&D platform in China.